New award for tacrolimus capsules with golden state medical supply, INC. Period of performance is april 1, 2021 through march 31, 2022 with four one year options.

Ended Indefinite Delivery Contract Awarded Last action

Contract number
36E79721D0001
Awardee
Awarding agency
Task orders
0

Award facts

Opportunity
Last date to order 100% complete
IDV ceiling
$56,233,029.00
Award type
Single award
Who can order
Only the awarding agency
Set-aside
No set-aside
Competition
Full and Open Competition · 4 offers Negotiated Proposal / Quote
Pricing
Firm Fixed Price

Award details come from SAM.gov/FPDS.

About this IDV

The federal contract IDV award is for the delivery of tacrolimus capsules in 0.5mg, 1mg, and 5mg package sizes to the Department of Veterans Affairs (VA), Department of Defense (DoD), Bureau of Prisons (BOP), and Indian Health Service (IHS). The contract was awarded to Golden State Medical Supply, Inc., a for-profit manufacturer and distributor of pharmaceuticals and medical products, for a one-year base period with four one-year option periods, with a total ceiling value of $56,233,029.

The original solicitation, 36E79720R0066, was issued by the VA National Acquisition Center under FAR Part 12 for commercial items, using NAICS code 325412. The solicitation was unrestricted, with no set-aside requirements. The contract aims to provide an uninterrupted source of tacrolimus capsules to the VA, DoD, BOP, and IHS, with estimated annual usage of 51,318 bottles of 0.5mg, 149,210 bottles of 1mg, and 5,449 bottles of 5mg capsules. This contract ensures clinicians have the ability to continue prescribing the branded product Prograf, while utilizing the awarded generic product when clinically appropriate.

Transactions

Action Obligated Date
Exercise an Option P00008 · Excerise 4TH and final option year effective 4/1/2025 through 3/31/2026 for tacrolimus capsules with golden state medical supply, INC. Prices remain unchanged. $0
Other Administrative Action P00007 · Manufacturer facility change EFFECTIVE11/1/2024 for tacrolimus capsules with golden state medical supply, INC. Prices remain unchanged. $0
Exercise an Option P00006 · Option year 3 effective 4/1/2024 through 3/31/2025 for tacrolimus capsules with golden state medical supply, INC. Prices remain unchanged. $0
Other Administrative Action P00005 · Incorporate CRF and submission of quarterly sales reports effective 2/14/2024 for tacrolimus capsules with golden state medical supply, INC. $0
Other Administrative Action P00004 · Incorporate dscsa effective 5/15/2023 for tacrolimus capsules with golden state medical supply, INC. $0
Exercise an Option P00003 · Exercise option year 2 effective 4/1/2023 through 3/31/2024 for tacrolimus capsules with golden state medical supply, INC. Prices remain unchanged. $0
Exercise an Option P00002 · Exercise option year 1 effective 4/1/2022 through 3/31/2023 for tacrolimus capsules with golden state medical supply, INC. Prices remain unchanged. $0
Other Administrative Action P00001 · Point of contact change for tacrolimus capsules with golden state medical supply, INC. $0
Original award $0

Quick answers

Who was awarded contract 36E79721D0001?

36E79721D0001 was awarded to Golden State Medical Supply, Inc. by National Acquisition Center (Headquarters) on April 1, 2021.

How much is contract 36E79721D0001 worth?

36E79721D0001's own ceiling is $56,233,029.

Who can order from contract 36E79721D0001?

36E79721D0001 is a single award indefinite delivery contract. Only the awarding agency can place orders on it.

Was contract 36E79721D0001 competed?

The extent of competition for 36E79721D0001 was full and open competition. The government received 4 offers.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV